Ocular Therapeutix Inc (OCUL)
6.10
+0.24
(+4.01%)
USD |
NASDAQ |
May 03, 10:56
Ocular Therapeutix Price to Book Value: 9.949 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 02, 2024 | 9.565 |
May 01, 2024 | 8.187 |
April 30, 2024 | 7.731 |
April 29, 2024 | 7.828 |
April 26, 2024 | 7.739 |
April 25, 2024 | 6.850 |
April 24, 2024 | 7.576 |
April 23, 2024 | 8.155 |
April 22, 2024 | 8.277 |
April 19, 2024 | 8.513 |
April 18, 2024 | 9.557 |
April 17, 2024 | 12.36 |
April 16, 2024 | 12.70 |
April 15, 2024 | 12.72 |
April 12, 2024 | 13.03 |
April 11, 2024 | 13.50 |
April 10, 2024 | 12.90 |
April 09, 2024 | 13.32 |
April 08, 2024 | 13.03 |
April 05, 2024 | 13.76 |
April 04, 2024 | 13.81 |
April 03, 2024 | 13.78 |
April 02, 2024 | 13.83 |
April 01, 2024 | 14.17 |
March 28, 2024 | 14.84 |
Date | Value |
---|---|
March 27, 2024 | 15.18 |
March 26, 2024 | 15.00 |
March 25, 2024 | 15.35 |
March 22, 2024 | 15.48 |
March 21, 2024 | 16.55 |
March 20, 2024 | 16.15 |
March 19, 2024 | 15.82 |
March 18, 2024 | 15.40 |
March 15, 2024 | 15.43 |
March 14, 2024 | 15.10 |
March 13, 2024 | 15.64 |
March 12, 2024 | 15.15 |
March 11, 2024 | 15.87 |
March 08, 2024 | 16.28 |
March 07, 2024 | 16.91 |
March 06, 2024 | 17.66 |
March 05, 2024 | 13.79 |
March 04, 2024 | 13.73 |
March 01, 2024 | 13.56 |
February 29, 2024 | 12.69 |
February 28, 2024 | 12.55 |
February 27, 2024 | 12.49 |
February 26, 2024 | 12.49 |
February 23, 2024 | 12.44 |
February 22, 2024 | 12.24 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.896
Minimum
May 12 2022
132.44
Maximum
Jun 30 2023
24.96
Average
12.61
Median
Jul 09 2021
Price to Book Value Benchmarks
Amgen Inc | 26.83 |
Assertio Holdings Inc | 0.6918 |
CytomX Therapeutics Inc | -- |
EyePoint Pharmaceuticals Inc | 3.925 |
Regeneron Pharmaceuticals Inc | 3.964 |
Price to Book Value Related Metrics
PS Ratio | 8.633 |
PEG Ratio | -0.2164 |
Price | 6.10 |
Earnings Yield | -20.49% |
Market Cap | 906.63M |
PEGY Ratio | -0.2164 |